LAURYN SAENZ: Open Payments
NPI 1710669643 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 121 payments from 22 companies in 2025. Trend: 2023 $702 · 2024 $2,476 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $438 |
| ABBVIE INC. | 19 | $316 |
| Lilly USA, LLC | 11 | $250 |
| Amgen Inc. | 23 | $174 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $107 |
| Dexcom, Inc. | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $90 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
Products named: Ozempic, MOUNJARO, VRAYLAR, Wegovy, OTEZLA, AIRSUPRA, Kerendia, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
